The Quantellect read.As of Nov 19, 2026, 5 active firms cover Achieve Life Sciences Inc: 5 rate it Buy or better, 0 sit at Neutral, and 0 rate it Sell or worse, a buy consensus. Targets span $12.00 to $19.00, a moderate spread. The average target of $15.00 sits 144% above the current $6.14. The rating mix has stayed broadly stable, with Buy-side ratings edging up from 4 to 5 over recent months. On the fundamentals, the Street sees revenue growth near 0% this year and 0% next, consensus EPS building from about $-0.18 next quarter toward $-0.68 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS5 active firms
Buy
Strong Buy00%
Buy5100%
Neutral00%
Sell00%
Strong Sell00%
Based on 5 active firms as of Nov 19, 2026 (365-day activity window).
12-MONTH PRICE TARGET
$15.00
+144.3% upside
Average target across 5 active firms as of Nov 19, 2026 vs $6.14 current
Highest Target$19.00
Average Target$15.00
Lowest Target$12.00
Detailed analyst forecasts for ACHV
Showing 1–5 of 5 named analysts shown · 5 active firms in the rating projection
As of Nov 19, 2026, 5 of 5 active firms rate ACHV a Buy (0 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
ACHV EPS & revenue forecast
EPS · NEXT QUARTER
$-0.18
Range $-0.27 – $-0.03 · 7 analysts · -5% YoY
Next period, 7 analysts expect Achieve Life Sciences Inc to earn $-0.18 a share (range $-0.27 – $-0.03), versus $-0.19 a year earlier. Full-year consensus is $-1.34, growing to $-0.68 the year after.
REVENUE · NEXT QUARTER
$2.2M
Range $0 – $11.0M · 7 analysts · +0% YoY
Revenue is expected to reach $2.2M (range $0 – $11.0M), +0.0% year-over-year. Full-year consensus is $0, rising to $32.3M next year.
Top analysts covering Achieve Life Sciences Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on ACHV.
#1
Jason Butler
JMP Securities · Rank #62
Buy
$19.00+209.4% to target
Overall win rate
49%
+ Follow
#2
BF
Brandon Folkes
HC Wainwright & Co. · Rank #402
Buy
$12.00+95.4% to target
Overall win rate
38%
+ Follow
#3
Mark Smith
Lake Street · Rank #525
Buy
$11.00+79.2% to target
Overall win rate
32%
+ Follow
#4
Jason McCarthy
Maxim Group · Rank #567
Buy
$10.00+62.9% to target
Overall win rate
30%
+ Follow
#5
JC
James Condulis
Stifel
Buy
$18.00+193.2% to target
Coverage
—
+ Follow
ACHV stock forecast FAQ
What is ACHV's average 12-month price target?+
The 5 active firms with a live target average $15.00 for Achieve Life Sciences Inc over the next 12 months, ranging from a $19.00 high to a $12.00 low, as of Nov 19, 2026.
Is ACHV stock a Buy, Sell or Neutral right now?+
The current consensus is Buy. Of the 5 active firms as of Nov 19, 2026, 5 rate it Buy or Strong Buy, 0 rate it Neutral, and 0 rate it Sell or Strong Sell.
What are the highest and lowest price targets for ACHV?+
The Street-high target is $19.00 (Citizens), and the Street-low is $12.00 (HC Wainwright & Co.). The average of all 5 active-firm targets is $15.00.
How many active Wall Street firms cover ACHV?+
5 active firms have a recognized rating on Achieve Life Sciences Inc as of Nov 19, 2026, and 5 active firms carry a live 12-month price target.
Who is the most accurate analyst covering ACHV?+
Among analysts who currently cover ACHV, Jason Butler of JMP Securities has the strongest overall Quantellect track record (Rank #62). Their current call is Buy with a $19.00 target.
What is Achieve Life Sciences Inc's projected EPS for next quarter?+
The consensus estimate is $-0.18 per share (range $-0.27 – $-0.03) across 7 analysts. Full-year EPS is projected at $-1.34, rising to $-0.68 the following year.
How much revenue is Achieve Life Sciences Inc expected to report next quarter?+
Consensus revenue is $2.2M (range $0 – $11.0M). Full-year revenue is projected at $0, growing to $32.3M next year.
Have analysts been upgrading or downgrading ACHV lately?+
As of Nov 19, 2026, 5 of 5 active firms rate ACHV a Buy (0 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their ACHV calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.